ImmunoBiochem

Developer of an innovative biopharmaceutical company intended to develop novel biological therapeutics to address significant unmet needs in oncology and immuno-oncology. The company’s technology focuses on involving a proprietary technology to address the challenge of cancer heterogeneity in solid tumors with its tumor microenvironment-targeted antibody-drug conjugates that comprise a novel class of potentiated biological therapeutics,…